Scientific Company Directory
The latest research, products, and discoveries from the science industry’s leading companies and company divisions.
Scientific Products
From innovative tools to essential equipment and supplies, find everything you need to advance your research on our new Scientific Products page.
Search Scientific Products
At Stago, we work with you to design a comprehensive hemostasis solution to fit the unique needs of your laboratory. Our unique approach focuses on improving patient outcomes and reducing the overall cost of care. Rest assured with reliable results from our standardized testing platforms. Expert support services combined with a complete menu of routine and specialty assays enable you to focus on your patients while we focus on you.
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for the launch of precision medicine, enabled by DXRX - The Diagnostic Network®.
Dovetail Genomics, a part of Cantata Bio LLC, is reimagining the life sciences by unlocking access to genomic structure at an unparalleled level. Through Dovetail Genomics' proprietary proximity ligation technologies, the 3D architecture of the genome is captured alongside primary sequence information using standard next-generation sequencing (NGS) approaches. Researchers are using Dovetail Genomics' unique methods to solve complex problems including chromatin topology analysis, small and large structural variant detection, de novo chromosome assembly, haplotype phasing and microbiome analysis in the fields of epigenetics, developmental biology, cancer research, evolutionary biology and more. Find out more at dovetailgenomics.com.
DIMA Biotechnology Ltd. is a top biotech company specializing in preclinical research and development solutions for the Biopharma industry. We offer a wide range of pre-designed and validated antibody molecules for early-stage drug development, perfectly tailored to the research needs of BioPharma companies.
Our extensive portfolio includes over 5,000 readily available lead antibody molecules designed for approximately 350 drug targets. Each of these molecules comes with verified sequences and validation data. In the coming years, we aim to develop lead antibodies for all potential drug targets, reaffirming our commitment to speeding up antibody-based drug discovery for BioPharma companies through our antibodies and flexible partnership options.
Throughout our journey, we've been dedicated to innovating and optimizing various technologies for antibody-based drug development. Here's a brief overview of our cutting-edge platforms:
- DiMPro™ Membrane Protein Platform: We specialize in expressing and purifying membrane proteins using mammalian cells. Our extensive inventory comprises over 1,000 functional proteins, including 200+ active full-length multi-pass membrane proteins. We offer five distinct solutions for multi-pass transmembrane proteins, such as GPCRs and ion channels: Membrane Nanoparticle (MNP), Virus-Like Particle (VLP), Exosome (EXO), Detergent, and Synthetic Nanodisc.
- DimAb® Single B-Cell Antibody Discovery Platform: Our DimAb® B cell library enables customers to access over 10,000 positive hits in just one month.
- DiLibrary™ Mammalian Display Antibody Engineering Platform: Our proprietary platform excels in antibody humanization, affinity maturation, and other engineering applications. Antibodies engineered through this system demonstrate superior developability compared to those produced by phage or yeast display platforms.
DiAssayTM Antibody Evaluation Platform: We offer a range of screening processes to help drug developers identify the ideal hit molecules for their specific antibody drug modalities. We've developed three distinct platforms suitable for Bispecific Antibodies (BsAbs), Antibody-Drug Conjugates (ADCs),